This report describes the global market size of Gene Editing from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.
For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.
For the competitor segment, the report includes global key players of Gene Editing as well as some smaller players.
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029
This product will be delivered within 1-3 business days.
For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.
This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
For the competitor segment, the report includes global key players of Gene Editing as well as some smaller players.
The information for each competitor includes:
- Company Profile
- Business Information
- SWOT Analysis
- Revenue, Gross Margin and Market Share
Applications Segment:
- Drug Discovery
- Therapeutics
- Diagnostics
- Others
Companies Covered:
- CRISPR Therapeutics AG
- Intellia Therapeutics Inc.
- bluebird bio Inc.
- Ensoma Inc.
- Editas Medicine Inc.
- Beam Therapeutics Inc.
- Tessera Therapeutics Inc.
- Prime Medicine Inc
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
Chapter Four Market Landscape
Chapter 5 Market Trend Analysis
Chapter 6 Industry Chain Analysis
Chapter 7 Latest Market Dynamics
Chapter 8 Historical and Forecast Gene Editing Market in North America (2019-2029)
Chapter 9 Historical and Forecast Gene Editing Market in South America (2019-2029)
Chapter 10 Historical and Forecast Gene Editing Market in Asia & Pacific (2019-2029)
Chapter 11 Historical and Forecast Gene Editing Market in Europe (2019-2029)
Chapter 12 Historical and Forecast Gene Editing Market in MEA (2019-2029)
Chapter 13 Summary For Global Gene Editing Market (2019-2024)
Chapter 14 Global Gene Editing Market Forecast (2024-2029)
Chapter 15 Analysis of Global Key Vendors
Tables and Figures
Companies Mentioned
- CRISPR Therapeutics AG
- Intellia Therapeutics Inc.
- bluebird bio Inc.
- Ensoma Inc.
- Editas Medicine Inc.
- Beam Therapeutics Inc.
- Tessera Therapeutics Inc.
- Prime Medicine Inc
- Generation Bio